LY 404187

Known as: LY-404187, LY404187 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2012
02420012012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Positive allosteric modulation of AMPA receptor function has therapeutic potential in a number of psychiatric disorders and… (More)
Is this relevant?
2004
2004
Recent developments in the molecular biology and pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA… (More)
Is this relevant?
2004
2004
AMPA receptor potentiators enhance AMPA receptor-mediated glutamatergic neurotransmission and may have therapeutic potential as… (More)
Is this relevant?
2003
2003
Positive allosteric regulation of glutamate AMPA receptors involves conformational changes that can attenuate receptor… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2003
2003
Four positive modulators of AMPA-type glutamate receptors (cyclothiazide, CX614, LY404187 and S18986-1) given in acute or chronic… (More)
Is this relevant?
2002
2002
AMPA receptor activation has been demonstrated to increase the neuronal expression of brain derived neurotrophic factor (BDNF… (More)
Is this relevant?
2001
2001
The present study describes the activity of two novel potent and selective AMPA receptor potentiator molecules LY392098 and… (More)
Is this relevant?
2001
2001
Positive modulators of glutamate alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors can enhance cognitive… (More)
Is this relevant?
2001
2001
Enhancement of AMPA receptor mediated synaptic excitation has the potential to aid in the treatment of several psychiatric… (More)
Is this relevant?
2001
2001
The present study describes the pharmacological activity of two novel positive allosteric modulators at AMPA receptors in acutely… (More)
Is this relevant?